Actively Recruiting
Prevalence and Clinical Implications of HPV Infection in Male IBD Patients
Led by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Updated on 2025-09-12
384
Participants Needed
1
Research Sites
172 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study aims at describing the prevalence of Human Papillomavirus (HPV) infection in anal and oral samples of men with Inflammatory Bowel Disease (IBD) and detecting risk factors for the infection.
CONDITIONS
Official Title
Prevalence and Clinical Implications of HPV Infection in Male IBD Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with Crohn's disease or ulcerative colitis at least 3 months before enrollment
- Male
- Age between 18 and 79 years
You will not qualify if you...
- Diagnosed with unclassified Inflammatory Bowel Disease
- Having diarrhea with more than 3 bowel movements per day and rectal bleeding at enrollment
- History of full proctectomy
- Unable to provide required biological samples
- Unable to complete the questionnaire
- Refused to sign informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
Actively Recruiting
Research Team
A
Antonio Giordano, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here